MedPath

Methyxicare

Brand Name: Methyxicare

Generic Name: Methylprednisolone (as sodium succinate)

Active
Registration Number

DRP-6110-02

Dosage Form

Powder For Solution For Injection (I.M./ I.V.)

Issuance Date

June 14, 2024

Expiry Date

April 16, 2030

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength40 mg
PackagingUSP Type III Clear Glass Vial x 7.5mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Corticosteroid
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Methylprednisolone (as sodium succinate)Active
Monograph: methylprednisolone (as sodium succinate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform